Skip to main content
. 2021 Jun 5;3(4):686–688. doi: 10.1016/j.xkme.2021.04.005

Table 2.

Development of ESKD at 12 and 36 Months' Follow-up

Risk Group Low Risk (n = 34) Medium Risk (n = 59) High Risk (n = 26)
ESKD at 12 mo 1 (2.9%) 5 (8.5%) 7 (26.9%)
ESKD at 36 mo 2 (5.9%) 8 (13.6%) 8 (30.8%)
ESKD at 60 mo 2 (5.9%) 9 (15.3%) 9 (34.6%)

Abbreviation: ESKD, end-stage kidney disease.